Exhibit 006 · Product label
Gardasil prescribing information, clinical studies
In 7 clinical trials (5 Amorphous Aluminum Hydroxyphosphate Sulfate [AAHS]-controlled, 1 saline placebo-controlled, and 1 uncontrolled)
Most control recipients in the licensure trials received a "placebo" containing the vaccine’s aluminum adjuvant (amorphous aluminum hydroxyphosphate sulfate). A smaller group received a non-aluminum placebo.
- Source
- Merck Sharp & Dohme / U.S. Food and Drug Administration
- Date
- 2006 onward
- Quoted from
- Package insert, section 6.1 Clinical Trials Experience (revision 04/2015, p. 3-4); same section: AAHS control N = 13,023, saline placebo N = 594
- Grade
- Primary record
- Document
- https://www.fda.gov/media/74350/download
- Accessed
- 2026-11-09
- Cited by
- Findings citing this exhibit